Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
AiCuris and Lysando expand collaboration on Artilysin-based treatments
AiCuris and Lysando announced an expansion of their existing collaboration to develop and optimize Artilysin-based drug candidates for topical treatment of infected chronic wounds, including diabetic foot infections.